Follow
Thuy M  Hoang
Thuy M Hoang
Unknown affiliation
Verified email at utexas.edu
Title
Cited by
Cited by
Year
Pyridone-conjugated monobactam antibiotics with gram-negative activity
MF Brown, MJ Mitton-Fry, JT Arcari, R Barham, J Casavant, ...
Journal of medicinal chemistry 56 (13), 5541-5552, 2013
752013
The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
T Hoang, E Toler, K DeLong, NA Mafunda, SM Bloom, HC Zierden, ...
PLoS pathogens 16 (1), e1008236, 2020
732020
Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV
MJ Mitton-Fry, SJ Brickner, JC Hamel, L Brennan, JM Casavant, M Chen, ...
Bioorganic & medicinal chemistry letters 23 (10), 2955-2961, 2013
702013
Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus
CE Henry, YY Wang, Q Yang, T Hoang, S Chattopadhyay, T Hoen, ...
Acta biomaterialia 43, 61-70, 2016
692016
Preparation, Gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols
ME Flanagan, SJ Brickner, M Lall, J Casavant, L Deschenes, SM Finegan, ...
ACS medicinal chemistry letters 2 (5), 385-390, 2011
662011
Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth
T Hoang, H Zierden, A Date, J Ortiz, S Gumber, N Anders, P He, J Segars, ...
Journal of controlled release 295, 74-86, 2019
402019
Conceptual design of a universal donor screening approach for vaginal microbiota transplant
K DeLong, S Bensouda, F Zulfiqar, HC Zierden, TM Hoang, AG Abraham, ...
Frontiers in cellular and infection microbiology 9, 472788, 2019
392019
Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV
MJ Mitton-Fry, SJ Brickner, JC Hamel, R Barham, L Brennan, ...
Bioorganic & medicinal chemistry letters 27 (15), 3353-3358, 2017
392017
Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections
MJ Mitton-Fry, JT Arcari, MF Brown, JM Casavant, SM Finegan, ...
Bioorganic & medicinal chemistry letters 22 (18), 5989-5994, 2012
332012
Identifying metabolic inhibitors to reduce bacterial persistence
SG Mohiuddin, T Hoang, A Saba, P Karki, MA Orman
Frontiers in microbiology 11, 472, 2020
322020
Quantification of rifapentine, a potent antituberculosis drug, from dried blood spot samples using liquid chromatographic-tandem mass spectrometric analysis
TL Parsons, MA Marzinke, T Hoang, E Bliven-Sizemore, M Weiner, ...
Antimicrobial agents and chemotherapy 58 (11), 6747-6757, 2014
232014
Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema
T Hoang, AA Date, JO Ortiz, TW Young, S Bensouda, P Xiao, M Marzinke, ...
European Journal of Pharmaceutics and Biopharmaceutics 138, 23-29, 2019
222019
Validation and implementation of liquid chromatographic-mass spectrometric (LC–MS) methods for the quantification of tenofovir prodrugs
P Hummert, TL Parsons, LM Ensign, T Hoang, MA Marzinke
Journal of pharmaceutical and biomedical analysis 152, 248-256, 2018
222018
Hypo-osmolar formulation of tenofovir (TFV) enema promotes uptake and metabolism of TFV in tissues, leading to prevention of SHIV/SIV infection
P Xiao, S Gumber, MA Marzinke, AA Date, T Hoang, J Hanes, LM Ensign, ...
Antimicrobial agents and chemotherapy 62 (1), 10.1128/aac. 01644-17, 2018
212018
Characterization of an adapted murine model of intrauterine inflammation–induced preterm birth
HC Zierden, JIO Ortiz, P Dimitrion, V Laney, S Bensouda, NM Anders, ...
The American Journal of Pathology 190 (2), 295-305, 2020
112020
Cervicovaginal mucus barrier properties during pregnancy are impacted by the vaginal microbiome
HC Zierden, K DeLong, F Zulfiqar, JO Ortiz, V Laney, S Bensouda, ...
Frontiers in Cellular and Infection Microbiology 13, 1015625, 2023
72023
Identifying metabolic inhibitors to reduce bacterial persistence. Front Microbiol 11: 472
SG Mohiuddin, T Hoang, A Saba, P Karki, MA Orman
62020
Hypo-osmolar rectal enema TFV formulation prevents SHIV acquisition
P Xiao, S Gumber, M Marzinke, AA Date, T Hoang, J Hanes, LM Ensign, ...
Conference on Retroviruses and Opportunistic Infections, 2018
32018
Dysbiosis in vaginal microbiota alters cervicovaginal mucus barrier properties to HIV
T Hoang, K DeLong, E Toler, R Cone, J Hanes, L Ensign
AIDS RESEARCH AND HUMAN RETROVIRUSES 32, 281-281, 2016
22016
Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques
P Xiao, S Gumber, MA Marzinke, T Hoang, R Myers, AA Date, J Hanes, ...
JCI insight 7 (23), 2022
12022
The system can't perform the operation now. Try again later.
Articles 1–20